Recent Finacing
Recent Raise
Myotec Therapeutics is a London-based biopharma developing small-molecule therapeutics for wasting diseases, advancing lead candidate MT-102 into Phase II clinical studies for cancer cachexia and sarcopenia.
Recent Investors
Total Raised
Funding round
Investors